ELAB (PMGC Holdings) Moat Score: 2/10 (As of Jul. 12, 2026)


ELAB PMGC Holdings Inc ELAB
8 GF Score
Price $1.11
! 1 Warning Sign
View Full Analysis

What is PMGC Holdings Moat Score?

PMGC Holdings ELAB +5.16% 8 Moat Score is 2 as of Jul. 12, 2026. GuruFocus rates ELAB with a GF Score™ of 8/100. The stock has 1 warning sign investors should review. Among 1,396 Biotechnology companies, PMGC Holdings ranks better than 58.31% on this metric.

PMGC Holdings has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

PMGC Holdings has No Moat: PMGC Holdings Inc lacks significant market leadership, customer switching costs, or proprietary technology. The company does not exhibit strong brand strength or regulatory barriers, resulting in a very weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes PMGC Holdings might have No Moat - Very weak/transient advantages.

PMGC Holdings  (NAS:ELAB) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

PMGC Holdings Moat Score Related Terms

ELAB vs MBIO, PCSA, DRMA: Moat Score Comparison

For the Biotechnology subindustry, PMGC Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PMGC Holdings Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PMGC Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where PMGC Holdings's Moat Score falls into.


ELAB
8GF Score
PMGC Holdings Inc ELAB
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
PMGC Holdings (ELAB) has a Moat Score of 2 as of Jul. 12, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, PMGC Holdings ranks #582 out of 1396 companies in the Biotechnology industry, placing it in the top 41.7%.
Is PMGC Holdings' Moat Score too high?
PMGC Holdings' current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. PMGC Holdings' value of 2 is 0% at this industry median. Based on the distribution chart, PMGC Holdings ranks #582 out of 1396 companies in the Biotechnology industry, which is above the industry midpoint. Overall, PMGC Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does PMGC Holdings' Moat Score compare to MBIO and PCSA?
According to the Biotechnology industry distribution chart, PMGC Holdings ranks #582 out of 1396 companies for Moat Score. This puts PMGC Holdings in the upper half of its industry. The industry median Moat Score is 2.00. PMGC Holdings' value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,396 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PMGC Holdings's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMGC Holdings's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMGC Holdings stock overvalued right now?
PMGC Holdings (ELAB) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. PMGC Holdings' overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For PMGC Holdings (ELAB), the current Moat Score is 2 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PMGC Holdings Business Description

Address C/O 120 Newport Center Drive, Suite 250, Newport Beach, CA, USA, 92660
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
8GF Score

Get the complete analysis for ELAB

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.11
Price